CompletedNot Applicable

Tygacil Drug Use Investigation

116 participantsStarted 2013-04-15

Plain-language summary

Secondary Data Collection Study; safety and effectiveness of Tigecycline .under Japanese medical practice

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients who are prescribed tigecycline (Tygacil). Exclusion Criteria: * Subject who have not been prescribed tigecycline (Tygacil).

What they're measuring

Number of Participants With Adverse Drug Reaction (ADR)

Timeframe: Up until 14 days from the start date and 28 days from the end of the observation period

Trial details

NCT IDNCT01789905

SponsorPfizer

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2017-06-16

Results submitted2018-06-12

View on ClinicalTrials.gov More Intra-Abdominal Infections trials